ICD-10 Coding for High PSA(N40.0U, N41.9U, R97.2)
Learn about ICD-10 coding for high PSA, including documentation requirements and coding pitfalls. Ensure accurate billing and compliance with our comprehensive guide.
Complete code families applicable to High PSA
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R97.20 | Elevated prostate specific antigen [PSA] | Use for initial elevated PSA findings without a history of prostate cancer. |
|
| R97.21 | Rising PSA following treatment for malignant neoplasm of prostate | Use for patients with a history of prostate cancer and rising PSA levels post-treatment. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutHigh PSA
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting High PSA.
Not specifying if PSA test is screening or diagnostic
Impact
Clinical: May lead to inappropriate follow-up care., Regulatory: Potential for audit issues., Financial: Claims may be denied or delayed.
Mitigation
Clearly document the purpose of the PSA test., Use appropriate ICD-10 and CPT codes.
Using R97.20 without documented PSA value
Impact
Reimbursement: Claims may be denied due to lack of supporting documentation., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data reporting and analysis.
Mitigation
Ensure PSA levels are documented in the medical record.
Confusing screening vs. diagnostic codes
Impact
Reimbursement: Incorrect coding can lead to claim denials., Compliance: Potential audit risks., Data Quality: Misclassification of patient data.
Mitigation
Use Z12.5 for screening and R97.20 for diagnostic purposes.
PSA Testing Documentation
Impact
Lack of specific PSA values and clinical context in documentation.
Mitigation
Ensure all PSA results and clinical indications are documented.